drugset / Trial / NCT05970679
Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized, Double blind, Parallel, Multi-center, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A in Patient with primary Hypercholesterolemia or Mixed Dyslipidemia
Timeline
- Start
- 2022-08-17
- Primary completion
- 2023-04-13
- Completion
- 2023-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 5 mg | Oral |
| Subject | Atorvastatin | Small molecule | 10 mg | Oral |
| Subject | Ezetimibe | Unknown | 10 mg | Oral |